Page last updated: 2024-11-03

propafenone and Left Heart Hypoplasia Syndrome

propafenone has been researched along with Left Heart Hypoplasia Syndrome in 1 studies

Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.

Research Excerpts

ExcerptRelevanceReference
"Oral propafenone was administered and within 6 hours no further arrhythmias or side effects were noted."5.30Atrial flutter in a pediatric patient in the immediate period after the Fontan procedure: control with oral propafenone. ( Herzberg, GZ; Rossi, AF, 1997)
"Oral propafenone was administered and within 6 hours no further arrhythmias or side effects were noted."1.30Atrial flutter in a pediatric patient in the immediate period after the Fontan procedure: control with oral propafenone. ( Herzberg, GZ; Rossi, AF, 1997)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Herzberg, GZ1
Rossi, AF1

Other Studies

1 other study available for propafenone and Left Heart Hypoplasia Syndrome

ArticleYear
Atrial flutter in a pediatric patient in the immediate period after the Fontan procedure: control with oral propafenone.
    Pacing and clinical electrophysiology : PACE, 1997, Volume: 20, Issue:12 Pt 1

    Topics: Administration, Oral; Anti-Arrhythmia Agents; Atrial Flutter; Child, Preschool; Electrocardiography;

1997